FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Front Bioeng Biotechnol / Scalable Production of Equine Platelet Lysate for Multipoten...
Frontiers in bioengineering and biotechnology2021; 8; 613621; doi: 10.3389/fbioe.2020.613621

Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture.

Abstract: Translation of multipotent mesenchymal stromal cell (MSC)-based therapies is advancing in human and veterinary medicine. One critical issue is the culture of MSC before clinical use. Using fetal bovine serum (FBS) as supplement to the basal medium is still the gold standard for cultivation of many cell types including equine MSC. Alternatives are being explored, with substantial success using platelet lysate-supplemented media for human MSC. However, progress lags behind in the veterinary field. The aim of this study was to establish a scalable protocol for equine platelet lysate (ePL) production and to test the ePL in equine MSC culture. Whole blood was harvested into blood collection bags from 20 healthy horses. After checking sample materials for pathogen contamination, samples from 19 animals were included. Platelet concentrates were prepared using a buffy coat method. Platelets, platelet-derived growth factor BB, and transforming growth factor β1 concentrations were increased in the concentrates compared with whole blood or serum ( < 0.05), while white blood cells were reduced ( < 0.05). The concentrates were lysed using freeze/thaw cycles, which eliminated the cells while growth factor concentrations were maintained. Donor age negatively correlated with platelet and growth factor concentrations after processing ( < 0.05). Finally, all lysates were pooled and the ePL was evaluated as culture medium supplement in comparison with FBS, using adipose-derived MSC from four unrelated donor horses. MSC proliferated well in 10% FBS as well as in 10% ePL. However, using 5 or 2.5% ePL entailed highly inconsistent proliferation or loss of proliferation, with significant differences in generation times and confluencies ( < 0.05). MSC expressed the surface antigens CD90, CD44, and CD29, but CD73 and CD105 detection was low in all culture media. Adipogenic and osteogenic differentiation led to similar results in MSC from different culture media. The buffy coat method is useful to produce equine platelet concentrate with increased platelet and reduced white blood cell content in large scales. The ePL obtained supports MSC expansion similar as FBS when used at the same concentration (10%). Further investigations into equine MSC functionality in culture with ePL should follow.
Copyright © 2021 Hagen, Lehmann, Aurich, Bauer, Melzer, Moellerberndt, Patané, Schnabel and Burk.
Get Full Text
Publication Date: 2021-01-21 PubMed ID: 33553119PubMed Central: PMC7859354DOI: 10.3389/fbioe.2020.613621Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study focuses on developing a scalable production process of equine Platelet Lysate (ePL) and testing its efficiency in the culture of equine Multipotent Mesenchymal Stromal Cells (MSC). The aim is to provide an effective alternative to the current widely-used Fetal Bovine Serum (FBS) for the cultivation of equine MSC.

Collection and Preparation of Samples

  • Blood samples were collected from 20 healthy horses, and upon testing for pathogen contamination, 19 were included in the study.
  • Growth factors and platelets were collected from these samples after being concentrated using a buffy coat method.
  • This method also managed to reduce the content of white blood cells in the samples.
  • The concentrated platelets were then lysed through freeze/thaw cycles, eliminating the cells but maintaining the growth factor concentrations.
  • A negative correlation was observed between donor age and concentrations of platelets and growth factors.

Testing of Equine Platelet Lysate in MSC Culture

  • All lysates obtained were combined, culminating into the production of an ePL which was then used as a medium supplement in MSC culture, in comparison with FBS.
  • Adipose-derived MSCs from four unrelated horses were used for this experiment.
  • MSC proliferated well in both 10% FBS and 10% ePL, demonstrating the effectiveness of ePL as a growth medium.
  • However, lower concentrations of ePL (5% or 2.5%) led to inconsistent proliferation or complete loss of proliferation. Substantial differences were noted in generation times and confluences.

Analysis of MSC Expression and Differentiation

  • MSC in all culture media expressed CD90, CD44, and CD29 surface antigens while the detection of CD73 and CD105 was low.
  • Adipogenic and osteogenic differentiation of the MSC led to similar results irrespective of the culture media used.

Conclusion and Future Research

  • The buffy coat method showed usefulness in producing horse platelet concentrate which can be used in large-scale production.
  • This ePL also supports the expansion of MSC similarly to FBS, when used at identical concentrations (of 10%).
  • The study hence proposes that future research should focus on further researching equine MSC functionality in culture with ePL in an effort to establish ePL as an established alternative to FBS in cultivating equine MSC.

Cite This Article

APA
Hagen A, Lehmann H, Aurich S, Bauer N, Melzer M, Moellerberndt J, Patané V, Schnabel CL, Burk J. (2021). Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture. Front Bioeng Biotechnol, 8, 613621. https://doi.org/10.3389/fbioe.2020.613621

Publication

Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
NlmUniqueID: 101632513
Country: Switzerland
Language: English
Volume: 8
Pages: 613621
PII: 613621

Researcher Affiliations

Hagen, A
  • Equine Clinic (Surgery, Orthopedics), Justus-Liebig-University Giessen, Giessen, Germany.
Lehmann, H
  • Department of Veterinary Clinical Sciences, Small Animal Clinic, Justus-Liebig-University Giessen, Giessen, Germany.
Aurich, S
  • Institute of Hygiene and Infectious Diseases of Animals, Justus-Liebig-University Giessen, Giessen, Germany.
Bauer, N
  • Department of Veterinary Clinical Sciences, Clinical Pathology and Clinical Pathophysiology, Justus-Liebig-University Giessen, Giessen, Germany.
Melzer, M
  • Equine Clinic (Surgery, Orthopedics), Justus-Liebig-University Giessen, Giessen, Germany.
Moellerberndt, J
  • Equine Clinic (Surgery, Orthopedics), Justus-Liebig-University Giessen, Giessen, Germany.
Patané, V
  • Department of Veterinary Clinical Sciences, Clinical Pathology and Clinical Pathophysiology, Justus-Liebig-University Giessen, Giessen, Germany.
Schnabel, C L
  • Faculty of Veterinary Medicine, Institute of Immunology, Leipzig University, Leipzig, Germany.
Burk, J
  • Equine Clinic (Surgery, Orthopedics), Justus-Liebig-University Giessen, Giessen, Germany.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 100 references
  1. Anderson LD, Raub RH, Grieger DM, Morris J, Weber JD. Transforming growth factor-β1 concentrations in equine synovial fluid. J. Equine Vet. Sci. 18, 109–113.
    doi: 10.1016/S0737-0806(98)80289-Xgoogle scholar: lookup
  2. Astori G, Amati E, Bambi F, Bernardi M, Chieregato K, Schäfer R, Sella S, Rodeghiero F. Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future.. Stem Cell Res Ther 2016 Jul 13;7(1):93.
    doi: 10.1186/s13287-016-0352-xpmc: PMC4944312pubmed: 27411942google scholar: lookup
  3. Baker M. Reproducibility: Respect your cells!. Nature 2016 Sep 15;537(7620):433-5.
    doi: 10.1038/537433apubmed: 27629646google scholar: lookup
  4. Becherucci V, Piccini L, Casamassima S, Bisin S, Gori V, Gentile F, Ceccantini R, De Rienzo E, Bindi B, Pavan P, Cunial V, Allegro E, Ermini S, Brugnolo F, Astori G, Bambi F. Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience.. Stem Cell Res Ther 2018 May 2;9(1):124.
    doi: 10.1186/s13287-018-0863-8pmc: PMC5930506pubmed: 29720245google scholar: lookup
  5. Ben Azouna N, Jenhani F, Regaya Z, Berraeis L, Ben Othman T, Ducrocq E, Domenech J. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum.. Stem Cell Res Ther 2012 Feb 14;3(1):6.
    doi: 10.1186/scrt97pmc: PMC3340550pubmed: 22333342google scholar: lookup
  6. Bieback K. Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures.. Transfus Med Hemother 2013 Oct;40(5):326-35.
    doi: 10.1159/000354061pmc: PMC3822281pubmed: 24273486google scholar: lookup
  7. Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates.. Blood Rev 2009 Jul;23(4):177-89.
    doi: 10.1016/j.blre.2009.04.001pmc: PMC2720568pubmed: 19450911google scholar: lookup
  8. Blande IS, Bassaneze V, Lavini-Ramos C, Fae KC, Kalil J, Miyakawa AA, Schettert IT, Krieger JE. Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate.. Transfusion 2009 Dec;49(12):2680-5.
    doi: 10.1111/j.1537-2995.2009.02346.xpubmed: 19694997google scholar: lookup
  9. Bonelli F, Meucci V, Divers TJ, Wagner B, Intorre L, Sgorbini M. Kinetics of plasma procalcitonin, soluble CD14, CCL2 and IL-10 after a sublethal infusion of lipopolysaccharide in horses.. Vet Immunol Immunopathol 2017 Feb;184:29-35.
    doi: 10.1016/j.vetimm.2016.12.010pubmed: 28166929google scholar: lookup
  10. Boswell SG, Schnabel LV, Mohammed HO, Sundman EA, Minas T, Fortier LA. Increasing platelet concentrations in leukocyte-reduced platelet-rich plasma decrease collagen gene synthesis in tendons.. Am J Sports Med 2014 Jan;42(1):42-9.
    doi: 10.1177/0363546513507566pubmed: 24136860google scholar: lookup
  11. Bozorgmanesh R, Magdesian KG, Sutton-Burges JW, Owens SD, Tablin F. Equine platelet concentrate preparation and validation.. J Vet Intern Med 2019 May;33(3):1500-1506.
    doi: 10.1111/jvim.15472pmc: PMC6524399pubmed: 30868640google scholar: lookup
  12. Braun J, Hack A, Weis-Klemm M, Conrad S, Treml S, Kohler K, Walliser U, Skutella T, Aicher WK. Evaluation of the osteogenic and chondrogenic differentiation capacities of equine adipose tissue-derived mesenchymal stem cells.. Am J Vet Res 2010 Oct;71(10):1228-36.
    doi: 10.2460/ajvr.71.10.1228pubmed: 20919912google scholar: lookup
  13. Broeckx SY, Seys B, Suls M, Vandenberghe A, Mariën T, Adriaensen E, Declercq J, Van Hecke L, Braun G, Hellmann K, Spaas JH. Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses.. Stem Cells Dev 2019 Mar 15;28(6):410-422.
    doi: 10.1089/scd.2018.0061pmc: PMC6441287pubmed: 30623737google scholar: lookup
  14. Burnouf T, Goubran HA, Seghatchian J. Multifaceted regenerative lives of expired platelets in the second decade of the 21st century.. Transfus Apher Sci 2014 Oct;51(2):107-12.
    doi: 10.1016/j.transci.2014.08.006pubmed: 25189105google scholar: lookup
  15. Burnouf T, Strunk D, Koh MB, Schallmoser K. Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?. Biomaterials 2016 Jan;76:371-87.
    doi: 10.1016/j.biomaterials.2015.10.065pubmed: 26561934google scholar: lookup
  16. Chapman HS, Gale AL, Dodson ME, Linardi RL, Ortved KF. Autologous Platelet Lysate Does Not Enhance Chondrogenic Differentiation of Equine Bone Marrow-Derived Mesenchymal Stromal Cells Despite Increased TGF-β1 Concentration.. Stem Cells Dev 2020 Feb 1;29(3):144-155.
    doi: 10.1089/scd.2019.0239pubmed: 31802705google scholar: lookup
  17. Cholewa D, Stiehl T, Schellenberg A, Bokermann G, Joussen S, Koch C, Walenda T, Pallua N, Marciniak-Czochra A, Suschek CV, Wagner W. Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density.. Cell Transplant 2011;20(9):1409-22.
    doi: 10.3727/096368910X557218pubmed: 21396157google scholar: lookup
  18. Corash L. Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis.. Expert Rev Hematol 2011 Oct;4(5):509-25.
    doi: 10.1586/ehm.11.53pubmed: 21939419google scholar: lookup
  19. Del Bue M, Riccò S, Conti V, Merli E, Ramoni R, Grolli S. Platelet lysate promotes in vitro proliferation of equine mesenchymal stem cells and tenocytes.. Vet Res Commun 2007 Aug;31 Suppl 1:289-92.
    doi: 10.1007/s11259-007-0099-zpubmed: 17682897google scholar: lookup
  20. DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system.. Arthroscopy 2012 Jul;28(7):998-1009.
    doi: 10.1016/j.arthro.2012.04.148pubmed: 22738751google scholar: lookup
  21. Desjardins I, Theoret C, Joubert P, Wagner B, Lavoie JP. Comparison of TGF-beta 1 concentrations in bronchoalveolar fluid of horses affected with heaves and of normal controls.. Vet Immunol Immunopathol 2004 Oct;101(3-4):133-41.
    doi: 10.1016/j.vetimm.2004.03.008pubmed: 15350743google scholar: lookup
  22. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. Cytotherapy 2006;8(4):315-7.
    doi: 10.1080/14653240600855905pubmed: 16923606google scholar: lookup
  23. Donnelly BP, Nixon AJ, Haupt JL, Dahlgren LA. Nucleotide structure of equine platelet-derived growth factor-A and -B and expression in horses with induced acute tendinitis.. Am J Vet Res 2006 Jul;67(7):1218-25.
    doi: 10.2460/ajvr.67.7.1218pubmed: 16817746google scholar: lookup
  24. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, Lataillade JJ. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications.. J Cell Physiol 2005 Nov;205(2):228-36.
    doi: 10.1002/jcp.20391pubmed: 15887229google scholar: lookup
  25. Erickson GA, Bolin SR, Landgraf JG. Viral contamination of fetal bovine serum used for tissue culture: risks and concerns.. Dev Biol Stand 1991;75:173-5.
    pubmed: 1665460
  26. European Committee (Partial Agreement) on Blood Transfusion. Guide to the Preparation, Use and Quality Assurance of Blood Components. Technical Report. Council of Europe.
  27. European Medicines Agency London. Guideline on the Use of Bovine Serum in the Manufacture of Human Biological Medicinal Products. Technical Report EMA/CHMP/BWP/457920/2012 rev 1. Committee for Medicinal Products for Human Use (CHMP). European Medicines Agency.
    pubmed: 0
  28. Faraday N, Scharpf RB, Dodd-o JM, Martinez EA, Rosenfeld BA, Dorman T. Leukocytes can enhance platelet-mediated aggregation and thromboxane release via interaction of P-selectin glycoprotein ligand 1 with P-selectin.. Anesthesiology 2001 Jan;94(1):145-51.
    doi: 10.1097/00000542-200101000-00025pubmed: 11135734google scholar: lookup
  29. Ferris DJ, Frisbie DD, Kisiday JD, McIlwraith CW, Hague BA, Major MD, Schneider RK, Zubrod CJ, Kawcak CE, Goodrich LR. Clinical outcome after intra-articular administration of bone marrow derived mesenchymal stem cells in 33 horses with stifle injury.. Vet Surg 2014 Mar;43(3):255-65.
    doi: 10.1111/j.1532-950X.2014.12100.xpubmed: 24433318google scholar: lookup
  30. Gilbertie JM, Long JM, Schubert AG, Berglund AK, Schaer TP, Schnabel LV. Pooled Platelet-Rich Plasma Lysate Therapy Increases Synoviocyte Proliferation and Hyaluronic Acid Production While Protecting Chondrocytes From Synoviocyte-Derived Inflammatory Mediators.. Front Vet Sci 2018;5:150.
    doi: 10.3389/fvets.2018.00150pmc: PMC6039577pubmed: 30023361google scholar: lookup
  31. Giraldo CE, López C, Álvarez ME, Samudio IJ, Prades M, Carmona JU. Effects of the breed, sex and age on cellular content and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel.. BMC Vet Res 2013 Feb 12;9:29.
    doi: 10.1186/1746-6148-9-29pmc: PMC3577464pubmed: 23402541google scholar: lookup
  32. Gittel C, Brehm W, Burk J, Juelke H, Staszyk C, Ribitsch I. Isolation of equine multipotent mesenchymal stromal cells by enzymatic tissue digestion or explant technique: comparison of cellular properties.. BMC Vet Res 2013 Oct 29;9:221.
    doi: 10.1186/1746-6148-9-221pmc: PMC4228449pubmed: 24168625google scholar: lookup
  33. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.. Equine Vet J 2012 Jan;44(1):25-32.
    doi: 10.1111/j.2042-3306.2011.00363.xpubmed: 21615465google scholar: lookup
  34. Golebiewska EM, Poole AW. Platelet secretion: From haemostasis to wound healing and beyond.. Blood Rev 2015 May;29(3):153-62.
    doi: 10.1016/j.blre.2014.10.003pmc: PMC4452143pubmed: 25468720google scholar: lookup
  35. Gottipamula S, Sharma A, Krishnamurthy S, Majumdar AS, Seetharam RN. Human platelet lysate is an alternative to fetal bovine serum for large-scale expansion of bone marrow-derived mesenchymal stromal cells.. Biotechnol Lett 2012 Jul;34(7):1367-74.
    doi: 10.1007/s10529-012-0893-8pubmed: 22476583google scholar: lookup
  36. Griffiths S, Baraniak PR, Copland IB, Nerem RM, McDevitt TC. Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in vitro.. Cytotherapy 2013 Dec;15(12):1469-83.
    doi: 10.1016/j.jcyt.2013.05.020pubmed: 23981539google scholar: lookup
  37. Grimaud E, Heymann D, Rédini F. Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders.. Cytokine Growth Factor Rev 2002 Jun;13(3):241-57.
    doi: 10.1016/S1359-6101(02)00004-7pubmed: 12486877google scholar: lookup
  38. Grogan SP, Barbero A, Winkelmann V, Rieser F, Fitzsimmons JS, O'Driscoll S, Martin I, Mainil-Varlet P. Visual histological grading system for the evaluation of in vitro-generated neocartilage.. Tissue Eng 2006 Aug;12(8):2141-9.
    doi: 10.1089/ten.2006.12.2141pubmed: 16968155google scholar: lookup
  39. Gstraunthaler G. Alternatives to the use of fetal bovine serum: serum-free cell culture.. ALTEX 2003;20(4):275-81.
    pubmed: 14671707
  40. Gulliksson H. Platelets from platelet-rich-plasma versus buffy-coat-derived platelets: what is the difference?. Rev Bras Hematol Hemoter 2012;34(2):76-7.
    doi: 10.5581/1516-8484.20120024pmc: PMC3459400pubmed: 23049394google scholar: lookup
  41. Hackett CH, Flaminio MJ, Fortier LA. Analysis of CD14 expression levels in putative mesenchymal progenitor cells isolated from equine bone marrow.. Stem Cells Dev 2011 Apr;20(4):721-35.
    doi: 10.1089/scd.2010.0175pmc: PMC3128771pubmed: 20722500google scholar: lookup
  42. Hawkes PW. Fetal bovine serum: geographic origin and regulatory relevance of viral contamination. Bioresour. Bioprocess. 2:34.
    doi: 10.1186/s40643-015-0063-7google scholar: lookup
  43. Hillmann A, Ahrberg AB, Brehm W, Heller S, Josten C, Paebst F, Burk J. Comparative Characterization of Human and Equine Mesenchymal Stromal Cells: A Basis for Translational Studies in the Equine Model.. Cell Transplant 2016;25(1):109-24.
    doi: 10.3727/096368915X687822pubmed: 25853993google scholar: lookup
  44. Hoareau GL, Jandrey KE, Burges J, Bremer D, Tablin F. Comparison of the platelet-rich plasma and buffy coat protocols for preparation of canine platelet concentrates.. Vet Clin Pathol 2014 Dec;43(4):513-8.
    doi: 10.1111/vcp.12195pubmed: 25267468google scholar: lookup
  45. Hodgson J. To treat or not to treat: that is the question for serum.. Biotechnology (N Y) 1995 Apr;13(4):333-4, 337-8, 342-3.
    doi: 10.1038/nbt0495-333pubmed: 9634775google scholar: lookup
  46. Horn P, Bokermann G, Cholewa D, Bork S, Walenda T, Koch C, Drescher W, Hutschenreuther G, Zenke M, Ho AD, Wagner W. Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells.. Cytotherapy 2010 Nov;12(7):888-98.
    doi: 10.3109/14653249.2010.501788pubmed: 20662607google scholar: lookup
  47. Ionita J-C, Kissich C, Gottschalk J, Einspanier A, Köller G, Winter K. Comparison of cellular and growth factor concentrations in equine Autologous Conditioned Plasma® (ACP) and manually prepared Platelet Rich Plasma (mPRP). PHK 30, 195–201.
    doi: 10.21836/PEM20140208google scholar: lookup
  48. Jayme DW, Epstein DA, Conrad DR. Fetal bovine serum alternatives.. Nature 1988 Aug 11;334(6182):547-8.
    doi: 10.1038/334547a0pubmed: 3405300google scholar: lookup
  49. Jochems CE, van der Valk JB, Stafleu FR, Baumans V. The use of fetal bovine serum: ethical or scientific problem?. Altern Lab Anim 2002 Mar-Apr;30(2):219-27.
    doi: 10.1177/026119290203000208pubmed: 11971757google scholar: lookup
  50. Kabithe E, Hillegas J, Stokol T, Moore J, Wagner B. Monoclonal antibodies to equine CD14.. Vet Immunol Immunopathol 2010 Nov 15;138(1-2):149-53.
    doi: 10.1016/j.vetimm.2010.07.003pubmed: 20674042google scholar: lookup
  51. Karnieli O, Friedner OM, Allickson JG, Zhang N, Jung S, Fiorentini D, Abraham E, Eaker SS, Yong TK, Chan A, Griffiths S, Wehn AK, Oh S, Karnieli O. A consensus introduction to serum replacements and serum-free media for cellular therapies.. Cytotherapy 2017 Feb;19(2):155-169.
    doi: 10.1016/j.jcyt.2016.11.011pubmed: 28017599google scholar: lookup
  52. Klatte-Schulz F, Schmidt T, Uckert M, Scheffler S, Kalus U, Rojewski M, Schrezenmeier H, Pruss A, Wildemann B. Comparative Analysis of Different Platelet Lysates and Platelet Rich Preparations to Stimulate Tendon Cell Biology: An In Vitro Study.. Int J Mol Sci 2018 Jan 10;19(1).
    doi: 10.3390/ijms19010212pmc: PMC5796161pubmed: 29320421google scholar: lookup
  53. Kydd J, Antczak DF, Allen WR, Barbis D, Butcher G, Davis W, Duffus WP, Edington N, Grünig G, Holmes MA. Report of the First International Workshop on Equine Leucocyte Antigens, Cambridge, UK, July 1991.. Vet Immunol Immunopathol 1994 Jul;42(1):3-60.
    doi: 10.1016/0165-2427(94)90088-4pubmed: 7975180google scholar: lookup
  54. Lana JF, Macedo A, Ingrao ILG, Huber SC, Santos GS, Santana MHA. Leukocyte-rich PRP for knee osteoarthritis: Current concepts.. J Clin Orthop Trauma 2019 Oct;10(Suppl 1):S179-S182.
    doi: 10.1016/j.jcot.2019.01.011pmc: PMC6823820pubmed: 31700210google scholar: lookup
  55. Larson EM, Babasyan S, Wagner B. Phenotype and function of IgE-binding monocytes in equine Culicoides hypersensitivity.. PLoS One 2020;15(5):e0233537.
    doi: 10.1371/journal.pone.0233537pmc: PMC7244122pubmed: 32442209google scholar: lookup
  56. Lunn DP, Holmes MA, Antczak DF, Agerwal N, Baker J, Bendali-Ahcene S, Blanchard-Channell M, Byrne KM, Cannizzo K, Davis W, Hamilton MJ, Hannant D, Kondo T, Kydd JH, Monier MC, Moore PF, O'Neil T, Schram BR, Sheoran A, Stott JL, Sugiura T, Vagnoni KE. Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995.. Vet Immunol Immunopathol 1998 Mar 31;62(2):101-43.
    doi: 10.1016/S0165-2427(97)00160-8pubmed: 9638857google scholar: lookup
  57. Malikides N, Mollison PJ, Reid SW, Murray M. Haematological responses of repeated large volume blood collection in the horse.. Res Vet Sci 2000 Jun;68(3):275-8.
    doi: 10.1053/rvsc.2000.0376pubmed: 10877975google scholar: lookup
  58. Mariñas-Pardo L, García-Castro J, Rodríguez-Hurtado I, Rodríguez-García MI, Núñez-Naveira L, Hermida-Prieto M. Allogeneic Adipose-Derived Mesenchymal Stem Cells (Horse Allo 20) for the Treatment of Osteoarthritis-Associated Lameness in Horses: Characterization, Safety, and Efficacy of Intra-Articular Treatment.. Stem Cells Dev 2018 Sep 1;27(17):1147-1160.
    doi: 10.1089/scd.2018.0074pubmed: 29978736google scholar: lookup
  59. McClain AK, McCarrel TM. The effect of four different freezing conditions and time in frozen storage on the concentration of commonly measured growth factors and enzymes in equine platelet-rich plasma over six months.. BMC Vet Res 2019 Aug 14;15(1):292.
    doi: 10.1186/s12917-019-2040-4pmc: PMC6694589pubmed: 31412868google scholar: lookup
  60. Mishra A, Tummala P, King A, Lee B, Kraus M, Tse V, Jacobs CR. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation.. Tissue Eng Part C Methods 2009 Sep;15(3):431-5.
    doi: 10.1089/ten.tec.2008.0534pmc: PMC2819709pubmed: 19216642google scholar: lookup
  61. Mohammadi S, Nikbakht M, Malek Mohammadi A, Zahed Panah M, Ostadali MR, Nasiri H, Ghavamzadeh A. Human Platelet Lysate as a Xeno Free Alternative of Fetal Bovine Serum for the In Vitro Expansion of Human Mesenchymal Stromal Cells.. Int J Hematol Oncol Stem Cell Res 2016 Jul 1;10(3):161-71.
    pmc: PMC4969561pubmed: 27489592
  62. Mojica-Henshaw MP, Jacobson P, Morris J, Kelley L, Pierce J, Boyer M, Reems JA. Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures.. Cytotherapy 2013 Dec;15(12):1458-68.
    doi: 10.1016/j.jcyt.2013.06.014pubmed: 24199591google scholar: lookup
  63. Naskou MC, Sumner S, Berezny A, Copland IB, Peroni JF. Fibrinogen-Depleted Equine Platelet Lysate Affects the Characteristics and Functionality of Mesenchymal Stem Cells.. Stem Cells Dev 2019 Dec 1;28(23):1572-1580.
    doi: 10.1089/scd.2019.0070pubmed: 31637965google scholar: lookup
  64. Naskou MC, Sumner SM, Chocallo A, Kemelmakher H, Thoresen M, Copland I, Galipeau J, Peroni JF. Platelet lysate as a novel serum-free media supplement for the culture of equine bone marrow-derived mesenchymal stem cells.. Stem Cell Res Ther 2018 Mar 22;9(1):75.
    doi: 10.1186/s13287-018-0823-3pmc: PMC5863827pubmed: 29566772google scholar: lookup
  65. Pacini S, Spinabella S, Trombi L, Fazzi R, Galimberti S, Dini F, Carlucci F, Petrini M. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses.. Tissue Eng 2007 Dec;13(12):2949-55.
    doi: 10.1089/ten.2007.0108pubmed: 17919069google scholar: lookup
  66. Paebst F, Piehler D, Brehm W, Heller S, Schroeck C, Tárnok A, Burk J. Comparative immunophenotyping of equine multipotent mesenchymal stromal cells: an approach toward a standardized definition.. Cytometry A 2014 Aug;85(8):678-87.
    doi: 10.1002/cyto.a.22491pubmed: 24894974google scholar: lookup
  67. Patel RS, Tomlinson JE, Divers TJ, Van de Walle GR, Rosenberg BR. Single-cell resolution landscape of equine peripheral blood mononuclear cells reveals diverse cell types including T-bet(+) B cells.. BMC Biol 2021 Jan 22;19(1):13.
    doi: 10.1101/2020.05.05.077362v1doi: 10.1101/2020.05.05.077362pmc: PMC7820527pubmed: 33482825google scholar: lookup
  68. Pilz GA, Braun J, Ulrich C, Felka T, Warstat K, Ruh M, Schewe B, Abele H, Larbi A, Aicher WK. Human mesenchymal stromal cells express CD14 cross-reactive epitopes.. Cytometry A 2011 Aug;79(8):635-45.
    doi: 10.1002/cyto.a.21073pubmed: 21735544google scholar: lookup
  69. Prins HJ, Rozemuller H, Vonk-Griffioen S, Verweij VG, Dhert WJ, Slaper-Cortenbach IC, Martens AC. Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum.. Tissue Eng Part A 2009 Dec;15(12):3741-51.
    doi: 10.1089/ten.tea.2008.0666pubmed: 19519274google scholar: lookup
  70. Ranera B, Lyahyai J, Romero A, Vázquez FJ, Remacha AR, Bernal ML, Zaragoza P, Rodellar C, Martín-Burriel I. Immunophenotype and gene expression profiles of cell surface markers of mesenchymal stem cells derived from equine bone marrow and adipose tissue.. Vet Immunol Immunopathol 2011 Nov 15;144(1-2):147-54.
    doi: 10.1016/j.vetimm.2011.06.033pubmed: 21782255google scholar: lookup
  71. Renzi S, Riccò S, Dotti S, Sesso L, Grolli S, Cornali M, Carlin S, Patruno M, Cinotti S, Ferrari M. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report.. Res Vet Sci 2013 Aug;95(1):272-7.
    doi: 10.1016/j.rvsc.2013.01.017pubmed: 23419936google scholar: lookup
  72. Roscher K. Platelets in equids - an underrated biomarker?. DVG Service GmbH. Available online at: http://geb.uni-giessen.de/geb/volltexte/2019/14904/ (accessed October 01, 2020).
  73. Rubio-Azpeitia E, Andia I. Partnership between platelet-rich plasma and mesenchymal stem cells: in vitro experience.. Muscles Ligaments Tendons J 2014 Jan;4(1):52-62.
    doi: 10.11138/mltj/2014.4.1.052pmc: PMC4049651pubmed: 24932448google scholar: lookup
  74. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution.. Anal Quant Cytol Histol 2001 Aug;23(4):291-9.
    pubmed: 11531144
  75. Russell KA, Koch TG. Equine platelet lysate as an alternative to fetal bovine serum in equine mesenchymal stromal cell culture - too much of a good thing?. Equine Vet J 2016 Mar;48(2):261-4.
    doi: 10.1111/evj.12440pubmed: 25772755google scholar: lookup
  76. Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, Drexler C, Lanzer G, Linkesch W, Strunk D. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.. Transfusion 2007 Aug;47(8):1436-46.
    doi: 10.1111/j.1537-2995.2007.01220.xpubmed: 17655588google scholar: lookup
  77. Schallmoser K, Henschler R, Gabriel C, Koh MBC, Burnouf T. Production and Quality Requirements of Human Platelet Lysate: A Position Statement from the Working Party on Cellular Therapies of the International Society of Blood Transfusion.. Trends Biotechnol 2020 Jan;38(1):13-23.
    doi: 10.1016/j.tibtech.2019.06.002pubmed: 31326128google scholar: lookup
  78. Schallmoser K, Rohde E, Bartmann C, Obenauf AC, Reinisch A, Strunk D. Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells.. Biomed Mater Eng 2009;19(4-5):271-6.
    doi: 10.3233/BME-2009-0591pubmed: 20042793google scholar: lookup
  79. De Schauwer C, Meyer E, Van de Walle GR, Van Soom A. Markers of stemness in equine mesenchymal stem cells: a plea for uniformity.. Theriogenology 2011 May;75(8):1431-43.
    doi: 10.1016/j.theriogenology.2010.11.008pubmed: 21196039google scholar: lookup
  80. De Schauwer C, Piepers S, Van de Walle GR, Demeyere K, Hoogewijs MK, Govaere JL, Braeckmans K, Van Soom A, Meyer E. In search for cross-reactivity to immunophenotype equine mesenchymal stromal cells by multicolor flow cytometry.. Cytometry A 2012 Apr;81(4):312-23.
    doi: 10.1002/cyto.a.22026pubmed: 22411893google scholar: lookup
  81. De Schauwer C, Van de Walle GR, Van Soom A, Meyer E. Mesenchymal stem cell therapy in horses: useful beyond orthopedic injuries?. Vet Q 2013 Dec;33(4):234-41.
    doi: 10.1080/01652176.2013.800250pubmed: 23697553google scholar: lookup
  82. Schnabel CL, Babasyan S, Freer H, Wagner B. CXCL10 production in equine monocytes is stimulated by interferon-gamma.. Vet Immunol Immunopathol 2019 Jan;207:25-30.
    doi: 10.1016/j.vetimm.2018.11.016pubmed: 30593347google scholar: lookup
  83. Schubert S, Brehm W, Hillmann A, Burk J. Serum-free human MSC medium supports consistency in human but not in equine adipose-derived multipotent mesenchymal stromal cell culture.. Cytometry A 2018 Jan;93(1):60-72.
    doi: 10.1002/cyto.a.23240pubmed: 28926198google scholar: lookup
  84. Seo JP, Tsuzuki N, Haneda S, Yamada K, Furuoka H, Tabata Y, Sasaki N. Comparison of allogeneic platelet lysate and fetal bovine serum for in vitro expansion of equine bone marrow-derived mesenchymal stem cells.. Res Vet Sci 2013 Oct;95(2):693-8.
    doi: 10.1016/j.rvsc.2013.04.024pubmed: 23683731google scholar: lookup
  85. Shih DT, Chen JC, Chen WY, Kuo YP, Su CY, Burnouf T. Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally inactivated allogeneic human platelet lysate.. Transfusion 2011 Apr;51(4):770-8.
    doi: 10.1111/j.1537-2995.2010.02915.xpubmed: 21044088google scholar: lookup
  86. Smith RK, Korda M, Blunn GW, Goodship AE. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.. Equine Vet J 2003 Jan;35(1):99-102.
    doi: 10.2746/042516403775467388pubmed: 12553472google scholar: lookup
  87. Stokol T. Hematology Red Flags: The Value of Blood Smear Examination in Horses.. Vet Clin North Am Equine Pract 2020 Apr;36(1):15-33.
    doi: 10.1016/j.cveq.2019.11.001pubmed: 31959376google scholar: lookup
  88. Sumner SM, Naskou MC, Thoresen M, Copland I, Peroni JF. Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors.. Transfusion 2017 Jul;57(7):1755-1762.
    doi: 10.1111/trf.14124pubmed: 28439897google scholar: lookup
  89. Sundin M, Ringdén O, Sundberg B, Nava S, Götherström C, Le Blanc K. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients.. Haematologica 2007 Sep;92(9):1208-15.
    doi: 10.3324/haematol.11446pubmed: 17666368google scholar: lookup
  90. Tesfaigzi MD. CD14 - an overview | ScienceDirect Topics. Available online at: https://www.sciencedirect.com/topics/neuroscience/cd14 (accessed October 01, 2020).
  91. Textor JA, Tablin F. Activation of equine platelet-rich plasma: comparison of methods and characterization of equine autologous thrombin.. Vet Surg 2012 Oct;41(7):784-94.
    doi: 10.1111/j.1532-950X.2012.01016.xpubmed: 22742830google scholar: lookup
  92. Trento C, Bernardo ME, Nagler A, Kuçi S, Bornhäuser M, Köhl U, Strunk D, Galleu A, Sanchez-Guijo F, Gaipa G, Introna M, Bukauskas A, Le Blanc K, Apperley J, Roelofs H, Van Campenhout A, Beguin Y, Kuball J, Lazzari L, Avanzini MA, Fibbe W, Chabannon C, Bonini C, Dazzi F. Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation.. Biol Blood Marrow Transplant 2018 Nov;24(11):2365-2370.
    doi: 10.1016/j.bbmt.2018.07.015pmc: PMC6299357pubmed: 30031938google scholar: lookup
  93. van der Valk J, Brunner D, De Smet K, Fex Svenningsen A, Honegger P, Knudsen LE, Lindl T, Noraberg J, Price A, Scarino ML, Gstraunthaler G. Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods.. Toxicol In Vitro 2010 Jun;24(4):1053-63.
    doi: 10.1016/j.tiv.2010.03.016pubmed: 20362047google scholar: lookup
  94. van der Valk J, Mellor D, Brands R, Fischer R, Gruber F, Gstraunthaler G, Hellebrekers L, Hyllner J, Jonker FH, Prieto P, Thalen M, Baumans V. The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture.. Toxicol In Vitro 2004 Feb;18(1):1-12.
    doi: 10.1016/j.tiv.2003.08.009pubmed: 14630056google scholar: lookup
  95. van Kuppeveld FJ, van der Logt JT, Angulo AF, van Zoest MJ, Quint WG, Niesters HG, Galama JM, Melchers WJ. Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification.. Appl Environ Microbiol 1992 Aug;58(8):2606-15.
    doi: 10.1128/AEM.58.8.2606-2615.1992pmc: PMC195828pubmed: 1381174google scholar: lookup
  96. Wagner B, Ainsworth DM, Freer H. Analysis of soluble CD14 and its use as a biomarker in neonatal foals with septicemia and horses with recurrent airway obstruction.. Vet Immunol Immunopathol 2013 Sep 1;155(1-2):124-8.
    doi: 10.1016/j.vetimm.2013.05.018pubmed: 23810420google scholar: lookup
  97. de Wildt-Eggen J, Schrijver JG, Bins M. WBC content of platelet concentrates prepared by the buffy coat method using different processing procedures and storage solutions.. Transfusion 2001 Nov;41(11):1378-83.
    doi: 10.1046/j.1537-2995.2001.41111378.xpubmed: 11724981google scholar: lookup
  98. World Health Organization. WHO Guidelines on Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies. Available online at: https://www.who.int/bloodproducts/cs/TSEPUBLISHEDREPORT.pdf?ua=1 (accessed October 02, 2020).
  99. Yaneselli K, Barrachina L, Remacha AR, Algorta A, Vitoria A, Cequier A, Romero A, Vázquez FJ, Maisonnave J, Rodellar C. Effect of allogeneic platelet lysate on equine bone marrow derived mesenchymal stem cell characteristics, including immunogenic and immunomodulatory gene expression profile.. Vet Immunol Immunopathol 2019 Nov;217:109944.
    doi: 10.1016/j.vetimm.2019.109944pubmed: 31563725google scholar: lookup
  100. Zheng X, Baker H, Hancock WS, Fawaz F, McCaman M, Pungor E Jr. Proteomic analysis for the assessment of different lots of fetal bovine serum as a raw material for cell culture. Part IV. Application of proteomics to the manufacture of biological drugs.. Biotechnol Prog 2006 Sep-Oct;22(5):1294-300.
    doi: 10.1021/bp060121opubmed: 17022666google scholar: lookup

Citations

This article has been cited 17 times.
  1. Karimi E, Vahedi N, Sarbandi RR, Parandakh A, Ganjoury C, Sigaroodi F, Najmoddin N, Tabatabaei M, Tafazzoli-Shadpour M, Ardeshirylajimi A, Khani MM. Nanoscale vibration could promote tenogenic differentiation of umbilical cord mesenchymal stem cells. In Vitro Cell Dev Biol Anim 2023 Jun;59(6):401-409.
    doi: 10.1007/s11626-023-00780-4pubmed: 37405626google scholar: lookup
  2. Moellerberndt J, Hagen A, Niebert S, Büttner K, Burk J. Cytokines in equine platelet lysate and related blood products. Front Vet Sci 2023;10:1117829.
    doi: 10.3389/fvets.2023.1117829pubmed: 36968472google scholar: lookup
  3. Heyman E, Meeremans M, Devriendt B, Olenic M, Chiers K, De Schauwer C. Validation of a color deconvolution method to quantify MSC tri-lineage differentiation across species. Front Vet Sci 2022;9:987045.
    doi: 10.3389/fvets.2022.987045pubmed: 36311666google scholar: lookup
  4. Urzì O, Bagge RO, Crescitelli R. The dark side of foetal bovine serum in extracellular vesicle studies. J Extracell Vesicles 2022 Oct;11(10):e12271.
    doi: 10.1002/jev2.12271pubmed: 36214482google scholar: lookup
  5. Hagen A, Niebert S, Brandt VP, Holland H, Melzer M, Wehrend A, Burk J. Functional properties of equine adipose-derived mesenchymal stromal cells cultured with equine platelet lysate. Front Vet Sci 2022;9:890302.
    doi: 10.3389/fvets.2022.890302pubmed: 36016806google scholar: lookup
  6. Pilgrim CR, McCahill KA, Rops JG, Dufour JM, Russell KA, Koch TG. A Review of Fetal Bovine Serum in the Culture of Mesenchymal Stromal Cells and Potential Alternatives for Veterinary Medicine. Front Vet Sci 2022;9:859025.
    doi: 10.3389/fvets.2022.859025pubmed: 35591873google scholar: lookup
  7. Hagen A, Holland H, Brandt VP, Doll CU, Häußler TC, Melzer M, Moellerberndt J, Lehmann H, Burk J. Platelet Lysate for Mesenchymal Stromal Cell Culture in the Canine and Equine Species: Analogous but Not the Same. Animals (Basel) 2022 Jan 13;12(2).
    doi: 10.3390/ani12020189pubmed: 35049811google scholar: lookup
  8. Burk J, Melzer M, Hagen A, Lips KS, Trinkaus K, Nimptsch A, Leopold J. Phospholipid Profiles for Phenotypic Characterization of Adipose-Derived Multipotent Mesenchymal Stromal Cells. Front Cell Dev Biol 2021;9:784405.
    doi: 10.3389/fcell.2021.784405pubmed: 34926463google scholar: lookup
  9. Doll CU, Niebert S, Burk J. Mesenchymal Stromal Cells Adapt to Chronic Tendon Disease Environment with an Initial Reduction in Matrix Remodeling. Int J Mol Sci 2021 Nov 26;22(23).
    doi: 10.3390/ijms222312798pubmed: 34884602google scholar: lookup
  10. Wanes D, Naim HY, Dengler F. Proliferation and Differentiation of Intestinal Caco-2 Cells Are Maintained in Culture with Human Platelet Lysate Instead of Fetal Calf Serum. Cells 2021 Nov 5;10(11).
    doi: 10.3390/cells10113038pubmed: 34831260google scholar: lookup
  11. Melzer M, Schubert S, Müller SF, Geyer J, Hagen A, Niebert S, Burk J. Rho/ROCK Inhibition Promotes TGF-β3-Induced Tenogenic Differentiation in Mesenchymal Stromal Cells. Stem Cells Int 2021;2021:8284690.
    doi: 10.1155/2021/8284690pubmed: 34659420google scholar: lookup
  12. Sawicki S, Bugno-Poniewierska M, Żurowski J, Szmatoła T, Semik-Gurgul E, Bochenek M, Karnas E, Gurgul A. Comparative Transcriptome and MicroRNA Profiles of Equine Mesenchymal Stem Cells, Fibroblasts, and Their Extracellular Vesicles. Genes (Basel) 2025 Aug 5;16(8).
    doi: 10.3390/genes16080936pubmed: 40869984google scholar: lookup
  13. Egli P, Boone L, Huber L, Higgins C, Gaonkar PP, Arrington J, Naskou MC, Peroni J, Gordon J, Lascola KM. Pilot study characterizing a single pooled preparation of equine platelet lysate for nebulization in the horse. Front Vet Sci 2024;11:1488942.
    doi: 10.3389/fvets.2024.1488942pubmed: 39726585google scholar: lookup
  14. Bzinkowska A, Sarnowska A. Assessment of the Dose-Dependent Effect of Human Platelet Lysate on Wharton's Jelly-Derived Mesenchymal Stem/Stromal Cells Culture for Manufacturing Protocols. Stem Cells Cloning 2024;17:21-32.
    doi: 10.2147/SCCAA.S471118pubmed: 39386994google scholar: lookup
  15. Yaneselli K, Ávila G, Rossi A, Rial A, Castro S, Estradé MJ, Suárez G, Algorta A. Impact of different formulations of platelet lysate on proliferative and immune profile of equine mesenchymal stromal cells. Front Vet Sci 2024;11:1410855.
    doi: 10.3389/fvets.2024.1410855pubmed: 39161460google scholar: lookup
  16. Duysens J, Graide H, Niesten A, Mouithys-Mickalad A, Deby-Dupont G, Franck T, Ceusters J, Serteyn D. Culture and Immunomodulation of Equine Muscle-Derived Mesenchymal Stromal Cells: A Comparative Study of Innovative 2D versus 3D Models Using Equine Platelet Lysate. Cells 2024 Jul 31;13(15).
    doi: 10.3390/cells13151290pubmed: 39120320google scholar: lookup
  17. Moellerberndt J, Niebert S, Fey K, Hagen A, Burk J. Impact of platelet lysate on immunoregulatory characteristics of equine mesenchymal stromal cells. Front Vet Sci 2024;11:1385395.
    doi: 10.3389/fvets.2024.1385395pubmed: 38725585google scholar: lookup
Subscribe to our newsletter
Join 99,030 horse owners like you who receive our email updates on horse health and nutrition.